Skip to main content

Doximity Announces Fiscal 2026 Third Quarter Financial Results

Total revenues of $185.1 million, up 10% year-over-year

Net income of $61.6 million, margin of 33%

Adjusted EBITDA of $111.4 million, margin of 60%

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025.

“We’re proud to deliver another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. “Our newsfeed had more than 1 million quarterly active prescribers, our workflow products had 720,000 (a record QoQ jump), and our nascent AI products had over 300,000. In short, the addition of AI features across our platform has made us more useful than ever.”

Fiscal 2026 Third Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended December 31, 2024.

  • Revenue: Revenue of $185.1 million, versus $168.6 million, an increase of 10% year-over-year.
  • Net income and non-GAAP net income: Net income of $61.6 million, versus $75.2 million, representing a margin of 33.3%, versus 44.6%. Non-GAAP net income of $91.1 million, versus $91.4 million, representing a margin of 49.3%, versus 54.2%.
  • Adjusted EBITDA: Adjusted EBITDA of $111.4 million, versus $102.0 million, an increase of 9% year-over-year, representing adjusted EBITDA margins of 60.2%, versus 60.5%.
  • Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.31, versus $0.37, while non-GAAP diluted net income per share was $0.46, versus $0.45.
  • Operating cash flow and free cash flow: Operating cash flow of $60.9 million, versus $65.2 million, a decrease of 7% year-over-year, and free cash flow of $58.5 million, versus $63.4 million, a decrease of 8% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2026 as follows:

  • Revenue between $143 million and $144 million.
  • Adjusted EBITDA between $63.5 million and $64.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2026 as follows:

  • Revenue between $642.5 million and $643.5 million.
  • Adjusted EBITDA between $355.5 million and $356.5 million.

Stock Repurchase Program

Doximity’s board of directors authorized another program to repurchase up to $500 million of the Company’s Class A common stock. The repurchase program has no expiration date and is subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans.

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

December 31, 2025

 

March 31, 2025

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

64,838

 

$

209,614

Marketable securities

 

670,288

 

 

706,050

Accounts receivable, net

 

156,589

 

 

128,354

Prepaid expenses and other current assets

 

101,738

 

 

44,602

Total current assets

 

993,453

 

 

1,088,620

Property and equipment, net

 

17,055

 

 

13,656

Deferred income tax assets

 

14,842

 

 

60,014

Operating lease right-of-use assets

 

7,523

 

 

8,886

Intangible assets, net

 

37,266

 

 

23,072

Goodwill

 

84,973

 

 

67,940

Other assets

 

1,914

 

 

2,121

Total assets

$

1,157,026

 

$

1,264,309

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

4,785

 

$

1,356

Accrued expenses and other current liabilities

 

76,677

 

 

38,405

Deferred revenue, current

 

66,307

 

 

114,285

Operating lease liabilities, current

 

2,079

 

 

2,211

Total current liabilities

 

149,848

 

 

156,257

Deferred revenue, non-current

 

174

 

 

280

Operating lease liabilities, non-current

 

8,613

 

 

10,185

Contingent earn-out consideration liability, non-current

 

 

 

5,579

Other liabilities, non-current

 

19,093

 

 

9,383

Total liabilities

 

177,728

 

 

181,684

Stockholders' Equity

 

 

 

Preferred stock

 

 

 

Common stock

 

185

 

 

189

Additional paid-in capital

 

956,744

 

 

894,225

Accumulated other comprehensive income

 

1,396

 

 

1,323

Retained earnings

 

20,973

 

 

186,888

Total stockholders’ equity

 

979,298

 

 

1,082,625

Total liabilities and stockholders’ equity

$

1,157,026

 

$

1,264,309

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

Revenue

$

185,053

 

$

168,603

 

$

499,491

 

$

432,111

Cost of revenue(1)

 

18,701

 

 

14,181

 

 

50,919

 

 

41,407

Gross profit

 

166,352

 

 

154,422

 

 

448,572

 

 

390,704

Operating expenses(1):

 

 

 

 

 

 

 

Research and development

 

34,595

 

 

22,421

 

 

91,596

 

 

68,235

Sales and marketing

 

42,205

 

 

38,491

 

 

117,738

 

 

108,102

General and administrative

 

17,656

 

 

13,585

 

 

49,144

 

 

32,943

Impairment charge

 

 

 

 

 

 

 

2,304

Total operating expenses

 

94,456

 

 

74,497

 

 

258,478

 

 

211,584

Income from operations

 

71,896

 

 

79,925

 

 

190,094

 

 

179,120

Other income, net

 

8,902

 

 

9,915

 

 

27,790

 

 

26,060

Income before income taxes

 

80,798

 

 

89,840

 

 

217,884

 

 

205,180

Provision for income taxes

 

19,240

 

 

14,644

 

 

40,947

 

 

44,453

Net income

$

61,558

 

$

75,196

 

$

176,937

 

$

160,727

Net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

$

0.33

 

$

0.40

 

$

0.94

 

$

0.86

Diluted

$

0.31

 

$

0.37

 

$

0.88

 

$

0.80

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

187,478

 

 

187,161

 

 

187,721

 

 

186,344

Diluted

 

199,224

 

 

202,233

 

 

200,375

 

 

200,625

(1)

Costs and expenses include stock-based compensation expense as follows (in thousands):

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

Cost of revenue

$

2,899

 

$

2,818

 

$

8,723

 

$

8,373

Research and development

 

13,654

 

 

4,471

 

 

30,165

 

 

14,602

Sales and marketing

 

9,926

 

 

6,487

 

 

28,144

 

 

19,881

General and administrative

 

7,067

 

 

5,592

 

 

17,853

 

 

11,470

Total stock-based compensation expense

$

33,546

 

$

19,368

 

$

84,885

 

$

54,326

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

$

61,558

 

 

$

75,196

 

 

$

176,937

 

 

$

160,727

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

3,989

 

 

 

2,655

 

 

 

10,252

 

 

 

7,830

 

Deferred income taxes

 

 

 

 

1,992

 

 

 

 

 

 

2,196

 

Stock-based compensation, net of amounts capitalized

 

33,546

 

 

 

19,368

 

 

 

84,885

 

 

 

54,326

 

Non-cash lease expense

 

459

 

 

 

441

 

 

 

1,363

 

 

 

1,392

 

Accretion of discount on marketable securities, net

 

(1,764

)

 

 

(3,368

)

 

 

(6,451

)

 

 

(8,736

)

Amortization of deferred contract costs

 

2,499

 

 

 

1,785

 

 

 

9,271

 

 

 

6,544

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

 

 

2,304

 

Other

 

295

 

 

 

411

 

 

 

181

 

 

 

289

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

(27,614

)

 

 

(12,986

)

 

 

(28,599

)

 

 

(36,464

)

Prepaid expenses and other assets

 

(12,828

)

 

 

1,303

 

 

 

(9,377

)

 

 

21,251

 

Deferred contract costs

 

(6,710

)

 

 

(5,853

)

 

 

(11,259

)

 

 

(9,069

)

Accounts payable, accrued expenses and other liabilities

 

41,855

 

 

 

9,418

 

 

 

39,522

 

 

 

3,872

 

Deferred revenue

 

(33,816

)

 

 

(24,628

)

 

 

(48,084

)

 

 

(30,085

)

Operating lease liabilities

 

(578

)

 

 

(545

)

 

 

(1,705

)

 

 

(1,599

)

Net cash provided by operating activities

 

60,891

 

 

 

65,189

 

 

 

216,936

 

 

 

174,778

 

Cash flows from investing activities

 

 

 

 

 

 

 

Cash paid for acquisition, net of cash acquired

 

 

 

 

 

 

 

(26,528

)

 

 

 

Purchases of intangible assets

 

(62

)

 

 

 

 

 

(62

)

 

 

 

Internal-use software development costs

 

(2,313

)

 

 

(1,771

)

 

 

(6,648

)

 

 

(5,018

)

Purchases of marketable securities

 

(112,922

)

 

 

(164,025

)

 

 

(381,122

)

 

 

(531,833

)

Maturities of marketable securities

 

143,136

 

 

 

99,308

 

 

 

413,167

 

 

 

517,221

 

Sales of marketable securities

 

10,386

 

 

 

7,564

 

 

 

10,386

 

 

 

14,805

 

Net cash provided by (used in) investing activities

 

38,225

 

 

 

(58,924

)

 

 

9,193

 

 

 

(4,825

)

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from issuance of common stock upon exercise of stock options and common stock warrants

 

2,221

 

 

 

3,662

 

 

 

7,017

 

 

 

13,905

 

Proceeds from issuance of common stock in connection with the employee stock purchase plan

 

 

 

 

 

 

 

1,816

 

 

 

1,422

 

Taxes paid related to net share settlement of equity awards

 

(8,869

)

 

 

(8,107

)

 

 

(33,362

)

 

 

(16,329

)

Repurchase of common stock

 

(196,879

)

 

 

(19,307

)

 

 

(341,127

)

 

 

(93,505

)

Payment of contingent consideration related to a business combination

 

 

 

 

 

 

 

(5,249

)

 

 

(5,470

)

Payment of excise taxes on share repurchases

 

 

 

 

(1,491

)

 

 

 

 

 

(1,491

)

Net cash used in financing activities

 

(203,527

)

 

 

(25,243

)

 

 

(370,905

)

 

 

(101,468

)

Net increase (decrease) in cash and cash equivalents

 

(104,411

)

 

 

(18,978

)

 

 

(144,776

)

 

 

68,485

 

Cash and cash equivalents, beginning of period

 

169,249

 

 

 

184,248

 

 

 

209,614

 

 

 

96,785

 

Cash and cash equivalents, end of period

$

64,838

 

 

$

165,270

 

 

$

64,838

 

 

$

165,270

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

Cash paid for taxes, net of refunds

$

1,675

 

 

$

13,829

 

 

$

21,022

 

 

$

35,814

 

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

  • Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of acquisition and other related expenses, stock-based compensation expense, amortization of acquired intangible assets, impairment charge, legal fees associated with certain non-ordinary course legal matters including the shareholder class action litigation, and change in fair value of contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
  • Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, impairment charge, legal fees associated with certain non-ordinary course legal matters including the shareholder class action litigation, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
  • Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment, purchases of intangible assets, and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

  • Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
  • Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

(unaudited)

 

(in thousands, except percentages)

Net income

$

61,558

 

 

$

75,196

 

 

$

176,937

 

 

$

160,727

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

1,616

 

 

 

 

Stock-based compensation

 

33,546

 

 

 

19,368

 

 

 

84,885

 

 

 

54,326

 

Depreciation and amortization

 

3,989

 

 

 

2,655

 

 

 

10,252

 

 

 

7,830

 

Provision for income taxes

 

19,240

 

 

 

14,644

 

 

 

40,947

 

 

 

44,453

 

Impairment charge

 

 

 

 

 

 

 

 

 

 

2,304

 

Change in fair value of contingent earn-out consideration liability

 

79

 

 

 

90

 

 

 

338

 

 

 

513

 

Legal expenses

 

1,886

 

 

 

 

 

 

4,813

 

 

 

 

Other income, net

 

(8,902

)

 

 

(9,915

)

 

 

(27,790

)

 

 

(26,060

)

Adjusted EBITDA

$

111,396

 

 

$

102,038

 

 

$

291,998

 

 

$

244,093

 

 

 

 

 

 

 

 

 

Revenue

$

185,053

 

 

$

168,603

 

 

$

499,491

 

 

$

432,111

 

Net income margin

 

33.3

%

 

 

44.6

%

 

 

35.4

%

 

 

37.2

%

Adjusted EBITDA margin

 

60.2

%

 

 

60.5

%

 

 

58.5

%

 

 

56.5

%

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

(unaudited)

 

(in thousands)

Net cash provided by operating activities

$

60,891

 

 

$

65,189

 

 

$

216,936

 

 

$

174,778

 

Purchases of intangible assets

 

(62

)

 

 

 

 

 

(62

)

 

 

 

Internal-use software development costs

 

(2,313

)

 

 

(1,771

)

 

 

(6,648

)

 

 

(5,018

)

Free cash flow

$

58,516

 

 

$

63,418

 

 

$

210,226

 

 

$

169,760

 

Other cash flow components:

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

$

38,225

 

 

$

(58,924

)

 

$

9,193

 

 

$

(4,825

)

Net cash used in financing activities

$

(203,527

)

 

$

(25,243

)

 

$

(370,905

)

 

$

(101,468

)

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

(unaudited)

 

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

18,701

 

 

$

14,181

 

 

$

50,919

 

 

$

41,407

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(2,899

)

 

 

(2,818

)

 

 

(8,723

)

 

 

(8,373

)

Non-GAAP cost of revenue

$

15,802

 

 

$

11,363

 

 

$

42,196

 

 

$

33,034

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

166,352

 

 

$

154,422

 

 

$

448,572

 

 

$

390,704

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

2,899

 

 

 

2,818

 

 

 

8,723

 

 

 

8,373

 

Non-GAAP gross profit

$

169,251

 

 

$

157,240

 

 

$

457,295

 

 

$

399,077

 

 

 

 

 

 

 

 

 

GAAP gross margin

 

89.9

%

 

 

91.6

%

 

 

89.8

%

 

 

90.4

%

Non-GAAP gross margin

 

91.5

%

 

 

93.3

%

 

 

91.6

%

 

 

92.4

%

 

 

 

 

 

 

 

 

GAAP research and development expense

$

34,595

 

 

$

22,421

 

 

$

91,596

 

 

$

68,235

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(13,654

)

 

 

(4,471

)

 

 

(30,165

)

 

 

(14,602

)

Amortization of acquired intangibles

 

(935

)

 

 

 

 

 

(1,558

)

 

 

 

Non-GAAP research and development expense

$

20,006

 

 

$

17,950

 

 

$

59,873

 

 

$

53,633

 

 

 

 

 

 

 

 

 

GAAP sales and marketing expense

$

42,205

 

 

$

38,491

 

 

$

117,738

 

 

$

108,102

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(9,926

)

 

 

(6,487

)

 

 

(28,144

)

 

 

(19,881

)

Amortization of acquired intangibles

 

(1,003

)

 

 

(1,061

)

 

 

(3,007

)

 

 

(3,183

)

Change in fair value of contingent earn-out consideration liability

 

(79

)

 

 

(90

)

 

 

(338

)

 

 

(513

)

Non-GAAP sales and marketing expense

$

31,197

 

 

$

30,853

 

 

$

86,249

 

 

$

84,525

 

 

 

 

 

 

 

 

 

GAAP general and administrative expense

$

17,656

 

 

$

13,585

 

 

$

49,144

 

 

$

32,943

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

(1,616

)

 

 

 

Stock-based compensation

 

(7,067

)

 

 

(5,592

)

 

 

(17,853

)

 

 

(11,470

)

Legal expenses

 

(1,886

)

 

 

 

 

 

(4,813

)

 

 

 

Non-GAAP general and administrative expense

$

8,703

 

 

$

7,993

 

 

$

24,862

 

 

$

21,473

 

 

 

 

 

 

 

 

 

GAAP operating expense

$

94,456

 

 

$

74,497

 

 

$

258,478

 

 

$

211,584

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

(1,616

)

 

 

 

Stock-based compensation

 

(30,647

)

 

 

(16,550

)

 

 

(76,162

)

 

 

(45,953

)

Amortization of acquired intangibles

 

(1,938

)

 

 

(1,061

)

 

 

(4,565

)

 

 

(3,183

)

Change in fair value of contingent earn-out consideration liability

 

(79

)

 

 

(90

)

 

 

(338

)

 

 

(513

)

Legal expenses

 

(1,886

)

 

 

 

 

 

(4,813

)

 

 

 

Impairment charge

 

 

 

 

 

 

 

 

 

 

(2,304

)

Non-GAAP operating expense

$

59,906

 

 

$

56,796

 

 

$

170,984

 

 

$

159,631

 

GAAP operating income

$

71,896

 

 

$

79,925

 

 

$

190,094

 

 

$

179,120

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

1,616

 

 

 

 

Stock-based compensation

 

33,546

 

 

 

19,368

 

 

 

84,885

 

 

 

54,326

 

Amortization of acquired intangibles

 

1,938

 

 

 

1,061

 

 

 

4,565

 

 

 

3,183

 

Change in fair value of contingent earn-out consideration liability

 

79

 

 

 

90

 

 

 

338

 

 

 

513

 

Legal expenses

 

1,886

 

 

 

 

 

 

4,813

 

 

 

 

Impairment charge

 

 

 

 

 

 

 

 

 

 

2,304

 

Non-GAAP operating income

$

109,345

 

 

$

100,444

 

 

$

286,311

 

 

$

239,446

 

 

 

 

 

 

 

 

 

GAAP net income

$

61,558

 

 

$

75,196

 

 

$

176,937

 

 

$

160,727

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

1,616

 

 

 

 

Stock-based compensation

 

33,546

 

 

 

19,368

 

 

 

84,885

 

 

 

54,326

 

Amortization of acquired intangibles

 

1,938

 

 

 

1,061

 

 

 

4,565

 

 

 

3,183

 

Change in fair value of contingent earn-out consideration liability

 

79

 

 

 

90

 

 

 

338

 

 

 

513

 

Legal expenses

 

1,886

 

 

 

 

 

 

4,813

 

 

 

 

Impairment charge

 

 

 

 

 

 

 

 

 

 

2,304

 

Income tax effect of non-GAAP adjustments (1)

 

(7,864

)

 

 

(4,309

)

 

 

(20,206

)

 

 

(12,668

)

Non-GAAP net income

$

91,143

 

 

$

91,406

 

 

$

252,948

 

 

$

208,385

 

Non-GAAP net income margin

 

49.3

%

 

 

54.2

%

 

 

50.6

%

 

 

48.2

%

 

 

 

 

 

 

 

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

187,478

 

 

 

187,161

 

 

 

187,721

 

 

 

186,344

 

Diluted

 

199,224

 

 

 

202,233

 

 

 

200,375

 

 

 

200,625

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share attributable to Class A and Class B stockholders:

 

 

 

 

 

 

 

Basic

$

0.49

 

 

$

0.49

 

 

$

1.35

 

 

$

1.12

 

Diluted

$

0.46

 

 

$

0.45

 

 

$

1.26

 

 

$

1.04

 

(1)

For the three and nine months ended December 31, 2025 and 2024, management used an estimated annual effective non-GAAP tax rate of 21.0%.

 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.69
-10.30 (-4.42%)
AAPL  275.91
-0.58 (-0.21%)
AMD  192.50
-7.69 (-3.84%)
BAC  54.94
-0.44 (-0.79%)
GOOG  331.33
-2.01 (-0.60%)
META  670.21
+1.22 (0.18%)
MSFT  393.67
-20.52 (-4.95%)
NVDA  171.88
-2.31 (-1.33%)
ORCL  136.48
-10.19 (-6.95%)
TSLA  397.21
-8.80 (-2.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.